Colorectal News and Research

RSS

DiaCarta partners with OncoAssure for prostate cancer test commercialization

DiaCarta, Inc., a pioneer in molecular diagnostic test development for cancer and infectious diseases, based in California, today announced that it has established a strategic collaboration with OncoAssure Ltd, an Irish medical diagnostics company headquartered at NovaUCD in Dublin.

27 Feb 2024

Insights into gut plasticity mechanisms unveiled through fruit fly research

One of the most striking examples of gut plasticity can be observed in animals that are exposed to prolonged periods of fasting, such as hibernating animals or phyton snakes that goes for months without eating, where the gut shrinks with as much as 50%, but recovers in size following a few days of re-feeding.

26 Feb 2024

Study links ultra-processed foods to gut health risks

A review in Nature Reviews Gastroenterology & Hepatology synthesizes evidence on the negative impacts of ultra-processed foods and food additives on gut health, linking them to chronic diseases and alterations in the gut microbiome.

25 Feb 2024

Study reveals over 134,000 missed cancer diagnoses in the U.S. during COVID-19 pandemic

Over 134,000 cancer cases went undiagnosed in the U.S. during the first 10 months of the COVID-19 pandemic, according to a new University of Kentucky Markey Cancer Center study.

23 Feb 2024

How did COVID-19 impact cancer incidence trends in the US?

Cancer rate patterns from March to December 2020.

23 Feb 2024

Off-the-shelf cancer vaccine shows promising results in patients with KRAS-mutated tumors

Samara Rahman, 74, considers herself lucky. She gets to take walks on the beach, go swimming and ride her bike -; all things that were taken from her when she was diagnosed with pancreatic cancer in November of 2022.

22 Feb 2024

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of the institution.

21 Feb 2024

Study evaluates colorectal cancer screening programs in Latin America

Little is known about colorectal cancer screening strategies throughout the Western Hemisphere, with the exception of the U.S. and Canada.

20 Feb 2024

Ultra-processed foods: A growing threat to public health

From fizzy drinks to cereals and packaged snacks to processed meat, ultra-processed foods are packed with additives.

20 Feb 2024

Associations between food additive emulsifiers and cancer risk

Researchers assessed associations between food emulsifier intake and cancer risk among NutriNet-Santé study participants.

19 Feb 2024

Impact of diet on health outcomes among United Kingdom Biobank participants

The association between diet and health outcomes among United Kingdom Biobank (UKBB) participants.

16 Feb 2024

Microgreens: Superfoods for the future, packed with nutrients and easy to grow

Review in Heliyon highlights the nutritional superiority, cultivation methods, and health benefits of microgreens, emphasizing their potential as a sustainable functional food amidst global health and environmental challenges.

12 Feb 2024

Smoking, drinking, and dietary habits linked to head and neck cancer risk, study finds

Study in JAMA Otolaryngology-Head & Neck Surgery examines the link between smoking, drinking, and dietary habits and the risk of developing head and neck cancer (HNC), highlighting the significant impact of lifestyle choices on cancer risk.

12 Feb 2024

Targeting gene-fibroblast interaction offers hope for treatment-resistant colon cancer

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 2, entitled, "PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance."

8 Feb 2024